20-63408500-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_172107.4(KCNQ2):​c.1800G>A​(p.Thr600Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,609,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T600T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

KCNQ2
NM_172107.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -6.49

Publications

0 publications found
Variant links:
Genes affected
KCNQ2 (HGNC:6296): (potassium voltage-gated channel subfamily Q member 2) The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and a related protein encoded by the KCNQ3 gene, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 1 (BFNC), also known as epilepsy, benign neonatal type 1 (EBN1). At least five transcript variants encoding five different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KCNQ2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neonatal encephalopathy with non-epileptic myoclonus
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neonatal-onset developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • seizures, benign familial neonatal, 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • seizures, benign familial neonatal, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign familial neonatal-infantile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign neonatal seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 20-63408500-C-T is Benign according to our data. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339. Variant chr20-63408500-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 129339.
BP7
Synonymous conserved (PhyloP=-6.49 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000329 (48/1457138) while in subpopulation SAS AF = 0.000152 (13/85610). AF 95% confidence interval is 0.0000895. There are 0 homozygotes in GnomAdExome4. There are 21 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 48 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ2NM_172107.4 linkc.1800G>A p.Thr600Thr synonymous_variant Exon 16 of 17 ENST00000359125.7 NP_742105.1 O43526-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ2ENST00000359125.7 linkc.1800G>A p.Thr600Thr synonymous_variant Exon 16 of 17 1 NM_172107.4 ENSP00000352035.2 O43526-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000415
AC:
10
AN:
240752
AF XY:
0.0000610
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000329
AC:
48
AN:
1457138
Hom.:
0
Cov.:
31
AF XY:
0.0000290
AC XY:
21
AN XY:
724700
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33436
American (AMR)
AF:
0.00
AC:
0
AN:
44362
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26022
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39576
South Asian (SAS)
AF:
0.000152
AC:
13
AN:
85610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51466
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1110694
Other (OTH)
AF:
0.00
AC:
0
AN:
60212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74348
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000241
AC:
1
AN:
41452
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 02, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy Benign:1
Nov 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.045
DANN
Benign
0.88
PhyloP100
-6.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780368; hg19: chr20-62039853; API